Results from the US National Health and Nutrition Examination Survey (NHANES 1999–2004) reported a prevalence of 8% for NAFLD in adolescents, based on elevated serum ALT [40]. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.